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Correction to: British Journal of Cancer (2009) 99, 1557–1563,
doi: 10.1038/sj.bjc.6604722
During proofing of the above paper, a number of mistakes were missed.
In the ‘Materials and Methods’ section, final paragraph (entitled
‘Statistical analysis’), the sentence beginning ‘The 24 month survival
rate was calculatedy’ should actually read ‘The 36-month survival
rate was calculatedy’
In Figure 1, the x axis labelling of the Pathology and Lymph node
metastasis columns was incorrect – the correct Figure and labelling
is shown below:
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www.bjcancer.comIn Figure 4, the x axis labelling of the Pathology and Lymph node
metastasis columns was again incorrect – the correct Figure and
labelling is shown below:
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